Atrial fibrillation: Stroke Neurologist Perspective

Authors

  • พรภัทร ธรรมสโรช ภาควิชาอายุรศาสตร์ คณะแพทยศาสตร์ มหาวิทยาลัยธรรมศาสตร์

Keywords:

ischemic stroke, atrial fibrillation, anticoagulant

Abstract

Atrial fibrillation (AF) is one of the most important risk factors of ischemic stroke and also usually found in the elderly. Prevalence of AF was 22% in Thai patients with ischemic stroke. Recent studies show the benefit of prolonged electrocardiography monitoring as atrial fibrillation more frequently detected. Prolonged rhythm monitoring (30- day) is recommended by American Stroke Association in stroke patients with unidentified cause. Studies showed that new oral anticoagulants can protect thromboembolic events with less major bleeding complications as compared to warfarin in patients with high-risk AF.

References

Wolf PA. Epidemiology of stroke. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, editors. Stroke: pathophysiology, diagnosis, and management. 4th ed.
Philadelphia: Churchill Livingstone; 2004. p.13-34.

Dharmasaroja P. Baseline characteristics of patients with acute ischemic stroke in a suburban area of Thailand. J Stroke Cerebrovasc Dis 2008;17:82-85.

Sutamnartpong P, Dharmasaroja PA, Ratanakorn D, et al. Atrial fibrillation and paroxysmal atrial fibrillation detection in patients with acute ischemic
stroke. J Stroke Cerebrovasc Dis 2014;23:1138-1141.

Dharmasaroja PA, Muengtaweepongsa S, Dharmasaroja P. Intravenous thrombolysis in Thai patients with acute ischemic stroke: role of aging. J Stroke
Cerebrovasc Dis 2013;22:227-231.

Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke : A guideline for healthcare professionals for the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.

Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014;370:2467-2477.

Sanna T, Diener HF, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370:2478-2486.

Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. A guideline for
healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2014;45:2160-2236.

พรภัทร ธรรมสโรช. วิทยาการระบาดของโรคหลอด เลือดสมองตีบและอุดตัน.ใน:พรภัทร ธรรมสโรช, บรรณาธิการ. โรคหลอดเลือดสมองตีบและอุดตัน. กรุงเทพมหานคร:จรัลสนิทวงศ์การพิมพ์;2555. น.1-21.

Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European Society of Cardiology. Europace 2010;12:1360-1420.

Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2872.

Lip GY, Frison L, Halperin J, et al. Identifying patients at risk of stroke despite anticoagulation. Stroke 2010;41:2731-2738.

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern
Med 1994;154:1449-1457.

Hylek EM, Skates SJ, Sheehan MA, et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial
fibrillation. N Engl J Med 1996;335:540-546.

Dale J, Myhre E, Storstein O, et al. Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled clinical study in patients with aortic ball
valves. Am Heart J 1977;94:101-111.

The ACTIVE investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009;360:1-13.

Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806-17.

Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-891.

Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151.

Downloads

Published

2019-02-19

How to Cite

1.
ธรรมสโรช พ. Atrial fibrillation: Stroke Neurologist Perspective. J Thai Stroke Soc [Internet]. 2019 Feb. 19 [cited 2024 Jun. 17];13(3):54-61. Available from: https://he01.tci-thaijo.org/index.php/jtss/article/view/173162

Issue

Section

Original article